Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;49(3):300060521999555.
doi: 10.1177/0300060521999555.

Association of dyslipidaemia with osteoporosis in postmenopausal women

Lingnan Zhang  1 , Qilong Liu  2 , Xianshang Zeng  3 , Wenshan Gao  4 , Yanan Niu  4 , Xiaoyong Ma  4 , Huijun Xie  4 , Xiaozhe Zhou  4 , Weiguang Yu  3 , Guixing Xu  5
Affiliations

Association of dyslipidaemia with osteoporosis in postmenopausal women

Lingnan Zhang et al. J Int Med Res. 2021 Mar.

Abstract

Objective: To assess the association of dyslipidaemia with osteoporosis in postmenopausal women.

Methods: Data from 160 postmenopausal women with newly diagnosed osteoporosis (osteoporosis group) and 156 healthy controls (control group) were retrospectively reviewed from 2016 to 2020. The primary outcomes were laboratory values assessed by a multivariate binary logistic regression model.

Results: Factors that greatly increased the risk of being in the osteoporosis group included high low-density lipoprotein (LDL) and low high-density lipoprotein (HDL) levels. The osteoporosis group had lower HDL and higher LDL levels than the control group. A multivariate binary logistic regression model showed that lower HDL and higher LDL levels were the only variables that were significantly associated with osteoporosis (odds ratio 1.86, 95% confidence interval: 3.66-4.25 and odds ratio 1.47, 95% confidence interval: 1.25-2.74, respectively).

Conclusion: Low HDL and high LDL levels may be associated with the occurrence of osteoporosis in postmenopausal women.

Keywords: Dyslipidaemia; bone mineral density; cholesterol; diabetes; high-density lipoprotein; low-density lipoprotein; osteoporosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Flow diagram showing selection of a cohort of postmenopausal women with newly diagnosed osteoporosis and reasons for exclusion. OS, osteoporosis.
See this image and copyright information in PMC

References

    1. Matsubara T, Ikeda F, Hata K, et al. Cbp Recruitment of Csk into Lipid Rafts Is Critical to c-Src Kinase Activity and Bone Resorption in Osteoclasts. J Bone Miner Res 2010; 25: 1068–1076. - PubMed
    1. Ongphiphadhanakul B, Chanprasertyothin S, Chailurkit L, et al. Differential associations of residual estradiol levels with bone mineral density and serum lipids in postmenopausal women with osteoporosis. Maturitas 2004; 48: 193–196. - PubMed
    1. Ozgocmen S, Kaya H, Fadillioglu E, et al. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007; 295: 45–52. - PubMed
    1. Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000; 20: 2346–2348. - PubMed
    1. Mori H, Okada Y, Kishikawa H, et al. Effects of raloxifene on lipid and bone metabolism in postmenopausal women with type 2 diabetes. J Bone Miner Metab 2013; 31: 89–95. - PubMed

Substances

LinkOut - more resources